TMA is excited to share the news about Medicare coverage for seat elevation for Medicare beneficiaries using power wheelchairs.
The Centers for Medicare & Medicaid Services (CMS) has made a significant expansion to its coverage policies for individuals relying on power wheelchairs. Effective immediately, Medicare will now cover seat elevation in power wheelchairs for Medicare beneficiaries. This decision comes as a result of extensive public input and advocacy efforts, demonstrating the power of community involvement and the impact it can have on healthcare policies.
Read more here for the final seat elevation Decision Memo.
#Rise4Access supporters
The coverage decision marks a milestone achievement for the #Rise4Access movement, a collective effort of wheelchair users, advocates, clinicians, and researchers. Their dedication and commitment to improve accessibility for individuals. CMS acknowledged the importance of their cause and recognized the need to address the challenges faced by Medicare beneficiaries who rely on power wheelchairs for their mobility related activities of daily living (MRADLs)
A great decision!
CMS’s decision to expand coverage for seat elevation in power wheelchairs is a direct result of public participation and engagement. The agency received an astounding 2,130 public comments, which included valuable insights and personal stories from individuals directly affected by this issue. The overwhelming response highlighted the pressing need for policy changes that recognize and address the unique challenges faced by Medicare beneficiaries who rely on power wheelchairs.
Many of the medical conditions may include myositis, rheumatoid arthritis, lupus, Parkinson’s disease, multiple sclerosis, cerebral palsy, spinal cord injury, paralysis, ALS, limb amputation, and other mobility-related conditions.
Working together, promoting progress
This decision underscores the importance of public advocacy and demonstrates that voices can affect change in healthcare policies. The dedication and perseverance of the Rise4Access movement and its supporters have created a lasting impact that will benefit countless individuals for years to come.
As we celebrate this milestone, it is important to remember that progress is driven by collective action. Community involvement and advocacy is so important. By working together, we can continue to shape policies, promote equality, and enhance accessibility.
Since be diagnosed with dermatomyositis my insurance company Blue Cross Blue Shield HMO has not approved this motility device for me. Any suggestions for me to help me get a motorized wheelchair.
Hello Karen, We’re sorry to hear your insurance company is denying this device for you. This article might help you find your way through the maze of insurance denials. It’s focus is medications, but you can use the same process for medical devices. We suggest you start by calling your insurance company to ask why they think your request is not necessary and ask what you need to do to prove that it is. Good luck!
https://www.myositis.org/patient-support/living-with-myositis/practical-resources/patient-assistance-programs/insurance-wont-pay-drug-doctor-prescribed-options/
Does Myositis foundation have recommended wheelchairs with power seat lift functions for IBM patients who have difficulty standing from a seated position
Janet, The Myositis Association knows how important these devices can be for those with IBM, but we prefer to let the experts–our members–evaluate them and make recommendations to each other. If you participate in one or more of our support or affinity groups, this is a good question to ask there. We suggest the Women with IBM group or your local support group.